文献速递临床试验与 GCP流行病学与生物统计

严重急性肾损伤延迟与早期启动肾脏替代治疗的系统综述与个体患者数据荟萃分析

Delayed versus early initiation of renal replacement therapy for severe acute kidney injury: a systematic review and individual patient data meta-analysis of randomised clinical trials.
PubMed 文献 · Lancet · 2020-04-23

该系统综述与个体患者数据荟萃分析纳入10项随机试验(2143例患者),比较延迟与早期启动肾脏替代治疗对严重急性肾损伤危重患者28天生存的影响。在无紧急指征时延迟启动并密切监测可减少RRT使用。

要点

  • 延迟与早期启动RRT的28天病死率无显著差异
  • 延迟组42%患者未接受RRT,可节约医疗资源
  • 无紧急指征时延迟启动RRT并密切监测是合理策略

核心结论

  • 在无紧急指征的严重急性肾损伤危重患者中,RRT启动时机不影响28天生存。
  • 延迟启动RRT并密切监测可减少RRT使用,节约医疗资源。

研究设计与样本

  • 系统综述与个体患者数据荟萃分析,检索MEDLINE、Embase和Cochrane Central至2019年12月20日。
  • 纳入10项随机试验共2143例患者,其中9项研究2083例有个体患者数据,1879例严重急性肾损伤患者被随机分配。

主要发现

  • 延迟组929例中有390例(42%)未接受RRT。

临床怎么用

  • 无紧急RRT指征时,可采取延迟启动策略并密切监测患者。
  • 延迟策略有望减少RRT使用,节省医疗资源。

局限性

  • 仅9项研究提供个体患者数据,1项符合标准的研究因招募期不够近被排除。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The timing of renal replacement therapy (RRT) for severe acute kidney injury is highly debated when no life-threatening complications are present. We assessed whether a strategy of delayed versus early RRT initiation affects 28-day survival in critically ill adults with severe acute kidney injury. METHODS: In this systematic review and individual patient data meta-analysis, we searched MEDLINE (via PubMed), Embase, and the Cochrane Central Register of Controlled Trials for randomised trials published from April 1, 2008, to Dec 20, 2019, that compared delayed and early RRT initiation strategies in patients with severe acute kidney injury. Trials were eligible for inclusion if they included critically ill patients aged 18 years or older with acute kidney injury (defined as a Kidney Disease: Improving Global Outcomes [KDIGO] acute kidney injury stage 2 or 3, or, where KDIGO was unavailable, a renal Sequential Organ Failure Assessment score of 3 or higher). We contacted the principal investigator of each eligible trial to request individual patient data. From the included trials, any patients without acute kidney injury or who were not randomly allocated were not included in the individual patient data meta-analysis. The primary outcome was all-cause mortality at day 28 after randomisation. This study is registered with PROSPERO (CRD42019125025). FINDINGS: Among the 1031 studies identified, one study that met the eligibility criteria was excluded because the recruitment period was not recent enough, and ten (including 2143 patients) were included in the analysis. Individual patient data were available for nine studies (2083 patients), from which 1879 patients had severe acute kidney injury and were randomly allocated: 946 (50%) to the delayed RRT group and 933 (50%) to the early RRT group. 390 (42%) of 929 patients allocated to the delayed RRT group and who had available data did not receive RRT. The proportion of patients who died by day 28 did not significantly differ between the delayed RRT group (366 [44%] of 837) and the early RRT group (355 [43%] of 827; risk ratio 1·01 [95% CI 0·91 to 1·13], p=0·80), corresponding to an overall risk difference of 0·01 (95% CI -0·04 to 0·06). There was no heterogeneity across studies (I2=0%; τ2=0), and most studies had a low risk of bias. INTERPRETATION: The timing of RRT initiation does not affect survival in critically ill patients with severe acute kidney injury in the absence of urgent indications for RRT. Delaying RRT initiation, with close patient monitoring, might lead to a reduced use of RRT, thereby saving health resources. FUNDING: None.

来源:Lancet,查看原文。版权归原作者所有。

引用

  1. Gaudry S, Hajage D, Benichou N, et al. Delayed versus early initiation of renal replacement therapy for severe acute kidney injury: a systematic review and individual patient data meta-analysis of randomised clinical trials. Lancet. 2020. PMID: 32334654. doi:10.1016/S0140-6736(20)30531-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。